Ask a team for its KOL list and you often get the doctors they know best. Or the ones who prescribe most.
Neither is a KOL list.
A key opinion leader is someone other doctors follow. That is a question about influence, and influence has to be mapped, not assumed.
How we build it in my teams:
Who shapes practice. Guideline authors, heads of department, the teachers younger doctors quote. Found from publications, guideline panels and teaching roles, not from call history.
What they need. Usually data, scientific exchange and honest answers to hard questions. Most of that belongs to medical affairs, not sales.
A genuine role. Speaker or adviser only when there is a documented need, contracted at fair market value.
The yearly review. Medical and marketing refresh the map together, because influence moves.
One rule sits above all of it. No engagement is ever linked to prescribing. Not in the plan, not in the conversation, not in the budget. If a KOL plan reads like a reward list, it is the wrong plan.
“A KOL is someone other doctors follow, not someone who likes us.”
Lesson 11 of 17 in Step 4: Distributors and market access, with the full guide and a checklist for this week.